For these thirty-one derivatives, a positive correlation was shown between HDAC IC50 and antiproliferative potency against the MV4-11 cell line, consistent with the hypothesis that the compounds evaluated target HDACs in these cancer cells. The gene discussed is HDAC9; the disease is cancer.